MicroRNA372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma

Citation:
and Abde, M. S. H. 4, M. A. Ragheb, E. M. Elzayat, M. S. Mohamed, N. El-Ekiaby, A. I. Abdelaziz, and A. - H. A. Abdel-Wahab, "MicroRNA372-3p Predicts Response of TACE Patients Treated with Doxorubicin and Enhances Chemosensitivity in Hepatocellular Carcinoma", Anti-Cancer Agents in Medicinal Chemistry, vol. 21, pp. 246-253, 2021.
PreviewAttachmentSize
anti-cancer_agents_in_medical_chemistry_6.pdf2.81 MB